Chongqing Pharscin Pharmaceutical Co., Ltd. (SHE:002907)

SHE:002907 Revenue

Chongqing Pharscin Pharmaceutical had revenue of 201.70M CNY in the quarter ending June 30, 2026, a decrease of -0.62%. This brings the company's total for the last twelve months to 798.78M, down -0.01% year-over-year. In the year 2025, Chongqing Pharscin Pharmaceutical had annual revenue of 827.14M with 6.75% growth. That makes Chongqing Pharscin Pharmaceutical the 21,292nd largest company in the world by revenue and 3,909th in China.

• Revenue (ttm): 798.78M
• Revenue Growth: -0.01%
• P/S Ratio: 7.15
• Revenue / Employee: n/a
• Employees: 1,439
• Market Cap: 5.71B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Industry 674.78M 81.6%
• Pharmaceutical Commercial 139.71M 16.9%
• Unallocated Other Operations 11.93M 1.4%
• Pharmaceutical Retail 726.33K 0.1%

By Geography

Chart

• Southwest Region 371.69M 44.9%
• East China 150.24M 18.2%
• Central China 147.50M 17.8%
• South China 60.74M 7.3%
• North China 49.97M 6.0%
• Northeast China 27.07M 3.3%
• Northwest Region 19.87M 2.4%
• Overseas 59.48K 0.0%

Fiscal year ended Dec 31, 2025 See the full SHE:002907 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	827.14M	52.32M	6.75%
Dec 31, 2024	774.82M	83.28M	12.04%
Dec 31, 2023	691.54M	-93.64M	-11.93%
Jan 1, 2023	785.18M	-60.96M	-7.20%
Jan 1, 2022	846.14M	-36.33M	-4.12%

Data Source: S&P Global Market Intelligence Last updated: Aug 20, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error